Class notes
Cursus Reumatologie
Volledige uitwerking reumatologie (REVAKI UGent)
[Show more]
Preview 4 out of 168 pages
Uploaded on
October 30, 2022
Number of pages
168
Written in
2021/2022
Type
Class notes
Professor(s)
/
Contains
All classes
Institution
Universiteit Gent (UGent)
Education
Revalidatiewetenschappen En Kinesitherapie
Course
Revaki Reumatologische Aandoeningen (D012210)
All documents for this subject (1)
$6.44
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
2021
Revalidatie en kinesitherapie bij
reumatologische aandoeningen
3DE BACHELOR REVALIDATIEWETENSCHAPPEN EN KINESITHERAPIE
UGENT
STIJN DEBUF
,REUMATOLOGIE – 3DE BACHELOR REVAKI UGENT
Revalidatie bij reumatologische aandoeningen
3de bachelor Revalidatiewetenschappen en Kinesitherapie – Universiteit Gent
1
,REUMATOLOGIE – 3DE BACHELOR REVAKI UGENT
INHOUDSTAFEL
Hoofdstuk 1 ....................................................................................................................................................................................... 6
Inleiding reumatologische aandoeningen en bindweefselziekten................................................................. 6
Reumatische systeemziekten of bindweefselziekten .................................................................................... 9
Systeemlupus .................................................................................................................................................. 9
Sjögren syndroom ......................................................................................................................................... 11
Polymyalgia reumatica .................................................................................................................................. 12
Idiopathische inflammatoire myositis ........................................................................................................... 13
Systeemsclerose ............................................................................................................................................ 14
Neoplasie – oncologie in de reumatologie .................................................................................................. 17
Bottumoren ................................................................................................................................................... 17
Paraneoplastische syndromen ...................................................................................................................... 19
Voorbeeldcasussen ....................................................................................................................................... 21
Hoofdstuk 2 ..................................................................................................................................................................................... 23
Osteoartritis (OA) ....................................................................................................................................... 23
Etiologie (OA) ................................................................................................................................................ 23
Epidemiologie en risicofactoren (OA) ........................................................................................................... 27
Diagnostiek (OA) ........................................................................................................................................... 28
Subtypes (OA)................................................................................................................................................ 30
Medische behandeling (OA) .......................................................................................................................... 32
Revalidatie (OA) ............................................................................................................................................ 35
Hoofdstuk 3 ..................................................................................................................................................................................... 49
Reumatoïde artritis (RA) ............................................................................................................................. 49
Inleiding (RA) ................................................................................................................................................. 49
Klinische manifestaties (RA) .......................................................................................................................... 49
Etiologie (RA) ................................................................................................................................................. 52
Diagnose (RA) ................................................................................................................................................ 53
Medische behandeling (RA) .......................................................................................................................... 58
Septische artritis (SA) ................................................................................................................................. 62
Inleiding (SA) ................................................................................................................................................. 62
Etiologie (SA) ................................................................................................................................................. 62
Diagnose (SA) ................................................................................................................................................ 63
Medische behandeling (SA)........................................................................................................................... 64
Kristalartritis (KA) ....................................................................................................................................... 66
Inleiding (KA) ................................................................................................................................................. 66
Etiologie JICHT ............................................................................................................................................... 66
2
, REUMATOLOGIE – 3DE BACHELOR REVAKI UGENT
Prevalentie JICHT........................................................................................................................................... 67
Diagnose JICHT .............................................................................................................................................. 67
Medische behandeling JICHT ........................................................................................................................ 68
Etiologie PSEUDOJICHT ................................................................................................................................. 69
Diagnose PSEUDOJICHT................................................................................................................................. 69
Medische behandeling PSEUDOJICHT ........................................................................................................... 70
Hoofdstuk 4 ..................................................................................................................................................................................... 71
Avasculaire necrose (aseptische necrose) ................................................................................................... 71
Inleiding ......................................................................................................................................................... 71
Symptomen ................................................................................................................................................... 72
Diagnostiek.................................................................................................................................................... 73
Oorzaken ....................................................................................................................................................... 76
Medische behandeling .................................................................................................................................. 78
Revalidatie ..................................................................................................................................................... 79
Hoofdstuk 5 ..................................................................................................................................................................................... 81
Abarticulaire klachten ................................................................................................................................ 81
Inleiding ......................................................................................................................................................... 81
Periartritis scapulohumeralis (PSH) ............................................................................................................... 81
Carpaaltunnel syndroom (CTS) ..................................................................................................................... 84
Kniekuilcyste (Baker’s Cyst) ........................................................................................................................... 86
Hoofdstuk 6 ..................................................................................................................................................................................... 88
Osteoporose ............................................................................................................................................... 88
Inleiding ......................................................................................................................................................... 88
Symptomatologie .......................................................................................................................................... 89
Diagnose ........................................................................................................................................................ 91
Pathogenese.................................................................................................................................................. 94
Preventie en therapie.................................................................................................................................... 96
Revalidatie bij osteoporose ......................................................................................................................... 104
Hoofdstuk 7 .................................................................................................................................................................................. 113
Spondyloartritis (SpA) .............................................................................................................................. 113
Inleiding SpA................................................................................................................................................ 113
Concept SpA ................................................................................................................................................ 119
Prevalentie SpA ........................................................................................................................................... 120
Algemene kenmerken SpA .......................................................................................................................... 121
Specifieke ziektebeelden SpA ..................................................................................................................... 128
Patient-partner program SpA ...................................................................................................................... 145
Revalidatie SpA............................................................................................................................................ 146
3